Biospective has both cuprizone and EAE multiple sclerosis mouse models. Biospective’s scientists work closely with sponsors to determine the most appropriate Cuprizone and EAE models, as well as biomarkers, to assess therapies targeting demyelination and remyelination, inflammation, and neuroprotection.